from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2234/ptpA

LFCtreatmentdescriptionclass of inhibitor

-0.707

Amikacinug/mL Amikacintranslation

-0.780

Cap5-10ug/mL Capreomycintranslation

0.002

Rox10-50 ug/mL Roxithromycintranslation

-0.462

SM2-5 ug/mL Streptomycintranslation

-1.693

Tet5-10 ug/mL Tetracyclinetranslation

0.302

Rif0.2-5ug/mL Rifampicintranscription

-0.572

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.225

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.166

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.236

CPZ10-50 ug/mL Chlorpromazinerespiration

0.460

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.065

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.928

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.867

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.054

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.416

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.249

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.079

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.651

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.838

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.114

KCN5-20 ug/mL Potassium cyaniderespiration

-1.279

NaN30.2-2 mM Sodium aziderespiration

0.465

Nigericin50 uM Nigericinrespiration

0.403

TRC10-150 ug/mL Triclosanrespiration

1.032

TRZ10-25 ug/mL Thioridazinerespiration

-0.140

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.452

menadione6-10 ug/mL Menadionerespiration

-0.227

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.679

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.393

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.439

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.709

NRP_1Non-replicating persistence stage 1dosRassociated

-0.647

Amp0.2mg/mL AmpicillincellWall

-0.242

Cephalexin20-100 ug/mL CephalexincellWall

-0.435

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.231

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.287

EMB10-20 ug/mL EthambutolcellWall

-0.563

Eta12-40 ug/mL EthionamidecellWall

-0.887

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.136

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.046

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.340

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.235

BZA0.12 mg/mL BenzamidearomaticAmides

-0.331

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.520

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.601

H2O24 mM hydrogen peroxideDNAdamaging

-0.261

Levo10 ug/mL LevofloxacinDNAdamaging

0.299

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.340

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.138

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.041

UVUV-irradiationDNAdamaging

-0.729

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.184

Antimycin12.5-50 ug/mL Antimycin A?

-0.009

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.008

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.091

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.380

PA8240.2-2 ug/mL PA-824?

1.506

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.301

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.044

Verapamil50 uM Verapamil?

0.493

mercaptoethanol2 mM 2-Mercaptoethanol?

0.141

methoxatin10-20 ug/mL Methoxatin?